Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
But newer GLP-1 pills aim to match, or even improve upon, their results
A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes
The latest on the scene: retatrutide , a so-called "triple-agonist" that targets GLP-1, GIP, and glucagon receptors
This was evidenced by increased alkaline phosphatase (ALP) activity, enhanced mineralization, and upregulation of osteogenic markers such as osteocalcin (OCN) and Runt-related transcription factor 2 (RUNX2)
They continue to offer retatrutide 40mg x2 Bundle (R&D Only) for 339.99
At a glance, this is how the two compare
US$ 29.51
US$ 24.47
US$ 24.18
US$ 27.79
US$ 21.21
US$ 23.17
US$ 26.03
